Mental healthcare barriers and facilitators experienced by homeless women with serious mental illness

2021 ◽  
pp. 1-10
Author(s):  
Kat La Mar ◽  
Lauren Mizock ◽  
Connie Veazey ◽  
Annabelle Nelson
Keyword(s):  
Mental Illness ◽  
Serious Mental Illness ◽  
Mental Healthcare ◽  
Homeless Women ◽  
Barriers And Facilitators ◽  
Healthcare Barriers

scholarly journals Creating a ‘reverse’ integrated primary and mental healthcare clinic for those with serious mental illness

2015 ◽  
Vol 17 (05) ◽  
pp. 421-427 ◽  
Author(s):  
Alexandros Maragakis ◽  
Ragavan Siddharthan ◽  
Jill RachBeisel ◽  
Cassandra Snipes
Keyword(s):  
Mental Health ◽  
Primary Care ◽  
Mental Illness ◽  
Quality Of Care ◽  
Serious Mental Illness ◽  
Mental Healthcare ◽  
Policy Reforms ◽  
Mental Health Settings ◽  
Primary Care Practitioners

Individuals with serious mental illness (SMI) are more likely to experience preventable medical health issues, such as diabetes, hyperlipidemia, obesity, and cardiovascular disease, than the general population. To further compound this issue, these individuals are less likely to seek preventative medical care. These factors result in higher usage of expensive emergency care, lower quality of care, and lower life expectancy. This manuscript presents literature that examines the health disparities this population experiences, and barriers to accessing primary care. Through the identification of these barriers, we recommend that the field of family medicine work in collaboration with the field of mental health to implement ‘reverse’ integrated care (RIC) systems, and provide primary care services in the mental health settings. By embedding primary care practitioners in mental health settings, where individuals with SMI are more likely to present for treatment, this population may receive treatment for somatic care by experts. This not only would improve the quality of care received by patients, but would also remove the burden of managing complex somatic care from providers trained in mental health. The rationale for this RIC system, as well as training and policy reforms, are discussed.

Clinical Applications and Investigation of the Acceptance of Mental Illness

2016 ◽  
pp. 146-158
Author(s):  
Lauren Mizock ◽  
Zlatka Russinova
Keyword(s):  
Mental Illness ◽  
Serious Mental Illness ◽  
Culturally Diverse ◽  
Clinical Care ◽  
Clinical Applications ◽  
Barriers And Facilitators ◽  
Future Research ◽  
Potential Development ◽  
Peer Specialists ◽  
Diverse Groups

This chapter reviews the 14 key principles of the process of acceptance of mental illness among culturally diverse groups that emerged from the findings in this book. Each principle is accompanied by clinical recommendations for facilitating the process of acceptance of mental illness. Examples are provided as to how clinicians, peer specialists, and researchers might respond to issues of acceptance of mental illness to facilitate hope and recovery. A number of acceptance-related techniques and theories in clinical care are also discussed. To further understanding and promote the process of acceptance of mental illness among persons in recovery, areas of potential development for future research are reviewed. An “Acceptance of Mental Illness Checklist” with scoring information is provided to assess the dimensions of acceptance and barriers and facilitators among people with serious mental illness and to aid further clinical and research examination of this construct.

In their own words: Trauma and substance abuse in the lives of formerly homeless women with serious mental illness.

2006 ◽  
Vol 76 (4) ◽  
pp. 461-467 ◽  
Author(s):  
Deborah K. Padgett ◽  
Robert Leibson Hawkins ◽  
Courtney Abrams ◽  
Andrew Davis
Keyword(s):  
Substance Abuse ◽  
Mental Illness ◽  
Serious Mental Illness ◽  
Homeless Women ◽  
Formerly Homeless

scholarly journals Perspectives of overweight Latinos with serious mental illness on barriers and facilitators to health behavior change.

2015 ◽  
Vol 3 (1) ◽  
pp. 11-22 ◽  
Author(s):  
Daniel E. Jimenez ◽  
Kelly Aschbrenner ◽  
Kimberly Burrows ◽  
Sarah I. Pratt ◽  
Margarita Alegría ◽  
...  
Keyword(s):  
Mental Illness ◽  
Health Behavior ◽  
Behavior Change ◽  
Serious Mental Illness ◽  
Health Behavior Change ◽  
Barriers And Facilitators

scholarly journals Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice.

2020 ◽  
Author(s):  
Kirsti Marieke Jakobs ◽  
Anne Posthuma ◽  
Wim JC de Grauw ◽  
Bianca WM Schalk ◽  
Reinier P Akkermans ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Mental Illness ◽  
Cardiovascular Risk ◽  
Family Practice ◽  
Serious Mental Illness ◽  
Mental Healthcare ◽  
Screening Rate ◽  
Risk Screening ◽  
Family Practices ◽  
Patients With Diabetes

Abstract Background: Patients with serious mental illness (SMI) and patients on antipsychotics (AP) have an elevated risk for cardiovascular diseases. In the Netherlands, the mental healthcare for these patients is increasingly taken care of by family practitioners (FP) as a result of a shift from secondary to primary care. Therefore, it is essential to increase our knowledge regarding the characteristics of this patient group and the (somatic) care provided by their FPs. The aim was to examine the rate of cardiovascular risk screening in patients with SMI or the use of AP in family practice.Methods: We performed a retrospective cohort study of 151.238 patients listed in 24 family practices in the Netherlands.From electronic medical records we extracted data concerning diagnoses, measurement values of CVR factors, medication and frequency of visits over a 2 year period. Primary outcome was the rate of patients who were screened for CVR factors. We compared three groups: patients with SMI/AP without diabetes or CVD (SMI/AP-only), patients with SMI/AP and diabetes mellitus (SMI/AP+DM), patients with SMI/AP and a history of cardiovascular disease (SMI/AP+CVD). We explored factors associated with adequate screening using multilevel logistic regression.Results: We identified 1705 patients with SMI/AP, 834 with a SMI diagnosis, 1150 using AP. The screening rate for CVR in the SMI/AP-only group (n=1383) was adequate in 8.5%. Screening was higher in the SMI/AP-+DM (n=206, 68.4% adequate, OR 24.6 (95%CI, 17.3-35.1) and SMI/AP+CVD (n=116, 26.7% adequate, OR 4.2 (95%CI, 2.7-6.6). A high frequency of visits, age, the use of AP and a diagnosis of COPD were associated with a higher screening rate. In addition we also examined differences between patients with SMI and patients using AP without SMI.Conclusion: CVR screening in patients with SMI/AP is performed poorly in Dutch family practices. Acceptable screening rates were found only among SMI/AP patients with diabetes mellitus as comorbidity. The finding of a large group of AP users without a SMI diagnosis may indicate that FPs often prescribe AP off-label, lack information about the diagnosis, or use the wrong code.

scholarly journals Qualitative systematic review of barriers and facilitators to patient-involved antipsychotic prescribing

BJPsych Open ◽  
2018 ◽  
Vol 4 (1) ◽  
pp. 5-14 ◽  
Author(s):  
Rebecca Pedley ◽  
Caitlin McWilliams ◽  
Karina Lovell ◽  
Helen Brooks ◽  
Kelly Rushton ◽  
...  
Keyword(s):  
Systematic Review ◽  
Mental Illness ◽  
Serious Mental Illness ◽  
Patient Involvement ◽  
Perceived Barriers ◽  
Barriers And Facilitators ◽  
Policy And Practice ◽  
Stakeholder Perspectives ◽  
Qualitative Systematic Review ◽  
Antipsychotic Prescribing

BackgroundDespite policy and practice mandates for patient involvement, people with serious mental illness often feel marginalised in decisions about antipsychotic medication.AimsTo examine stakeholder perspectives of barriers and facilitators to involving people with serious mental illness in antipsychotic prescribing decisions.MethodSystematic thematic synthesis.ResultsSynthesis of 29 studies identified the following key influences on involvement: patient's capability, desire and expectation for involvement, organisational context, and the consultation setting and processes.ConclusionsOptimal patient involvement in antipsychotic decisions demands that individual and contextual barriers are addressed. There was divergence in perceived barriers to involvement identified by patients and prescribers. For example, patients felt that lack of time in consultations was a barrier to involvement, something seldom raised by prescribers, who identified organisational barriers. Patients must understand their rights to involvement and the value of their expertise. Organisational initiatives should mandate prescriber responsibility to overcome barriers to involvement.Declaration of interestNone.

Sign in / Sign up

Export Citation Format

Share Document